Next-generation, feedback-responsive cell factories for recombinant protein manufacturing
用于重组蛋白制造的下一代反馈响应细胞工厂
基本信息
- 批准号:1930149
- 负责人:
- 金额:$ 38.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Proteins are used to treat a wide variety of diseases. These include several cancers, kidney failure and rheumatoid arthritis, to name a few. Production of therapeutic proteins has increased dramatically over the last decade and is expected to continue to rise for the next decade as treatments are developed for a larger number of diseases. Most of these proteins are produced from mammalian cells, which are the most capable of producing proteins with activity in humans. However, they are also limited in their ability to manufacture protein at large scale. This project will evaluate a number of strategies designed to increase protein production in mammalian cells. Education and training opportunities will target high school teachers and students from the Greater Houston area. This will enhance and diversify the pipeline of a STEM-ready workforce.Many complex recombinant proteins are manufactured in mammalian cells. The yield depends both on cell productivity and cell growth. Overexpression of recombinant proteins causes the accumulation of misfolded proteins and proteotoxic stress. These, in turn, lead to activation of a global response that may ultimately inhibit protein synthesis and reduce cell viability. This response culminates in the stimulation of protein degradation. The fate of the cell depends on the relative rates of activation of the signaling pathways involved in the response. The project team will use a recently-developed in-house technology to monitor gene expression with high sensitivity and dynamic resolution. Expression of markers of the protein quality control system upon overexpression of representative recombinant proteins will be profiled. Results will be used to generate strategies to remodel the stress response pathway, enhance quality control, and delay cell death in cells expressing high levels of recombinant proteins. Because of the fundamental role of the stress response in maintaining cellular homeostasis, results from this study will impact the design of a variety of cell engineering applications.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
蛋白质被用来治疗各种疾病。其中包括几种癌症,肾衰竭和类风湿性关节炎,仅举几例。治疗性蛋白质的产量在过去十年中大幅增加,随着针对更多疾病的治疗方法的开发,预计未来十年还将继续增加。这些蛋白质中的大多数是从哺乳动物细胞产生的,哺乳动物细胞是最有能力产生具有人类活性的蛋白质的细胞。然而,它们大规模制造蛋白质的能力也受到限制。该项目将评估一些旨在增加哺乳动物细胞蛋白质产量的策略。教育和培训机会将针对来自大休斯顿地区的高中教师和学生。这将增强和多样化STEM准备工作的管道。许多复杂的重组蛋白是在哺乳动物细胞中制造的。产量取决于细胞生产率和细胞生长。重组蛋白的过度表达会导致错误折叠蛋白的积累和蛋白毒性应激。反过来,这些又会导致全球反应的激活,最终可能会抑制蛋白质合成,降低细胞活力。这种反应在刺激蛋白质降解时达到顶峰。细胞的命运取决于参与反应的信号通路的相对激活速度。该项目团队将使用最近开发的一项内部技术,以高灵敏度和动态分辨率监测基因表达。蛋白质质量控制系统的标志物在具有代表性的重组蛋白过表达时的表达情况将被概述。结果将被用于制定策略,以重塑应激反应途径,加强质量控制,并延缓高水平重组蛋白表达细胞的细胞死亡。由于应激反应在维持细胞动态平衡方面的基础作用,这项研究的结果将影响各种细胞工程应用的设计。该奖项反映了NSF的法定使命,并通过使用基金会的智力优势和更广泛的影响审查标准进行评估,被认为值得支持。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A gene signal amplifier platform for monitoring the unfolded protein response.
用于监测未折叠蛋白质反应的基因信号放大器平台。
- DOI:10.1038/s41589-020-0497-x
- 发表时间:2020
- 期刊:
- 影响因子:14.8
- 作者:OrigelMarmolejo,CarlosA;Bachhav,Bhagyashree;Patibandla,SahitiD;Yang,AlexanderL;Segatori,Laura
- 通讯作者:Segatori,Laura
A yeast selection system for the detection of proteasomal activation
- DOI:10.1093/protein/gzz006
- 发表时间:2018-11-01
- 期刊:
- 影响因子:2.4
- 作者:Zhao,Wenting;Bachhav,Bhagyashree;Segatori,Laura
- 通讯作者:Segatori,Laura
The importance and future of biochemical engineering
- DOI:10.1002/bit.27364
- 发表时间:2020-05-29
- 期刊:
- 影响因子:3.8
- 作者:Whitehead, Timothy A.;Banta, Scott;Wheeldon, Ian
- 通讯作者:Wheeldon, Ian
Design of Oscillatory Networks through Post-Translational Control of Network Components
- DOI:10.35534/sbe.2023.10004
- 发表时间:2023-03
- 期刊:
- 影响因子:0
- 作者:Brianna Jayanthi;S. Jayanthi;Laura Segatori
- 通讯作者:Brianna Jayanthi;S. Jayanthi;Laura Segatori
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laura Segatori其他文献
Remodeling the Proteostasis Network to Rescue Glucocerebrosidase Variants by Inhibiting ER-Associated Degradation and Enhancing ER Folding
重塑蛋白质稳态网络,通过抑制内质网相关降解和增强内质网折叠来拯救葡萄糖脑苷脂酶变体
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:3.7
- 作者:
Fan Wang;Laura Segatori - 通讯作者:
Laura Segatori
Assembling Magnetic Colloidal Particles in Microfluidic Devices by WeijiaXie
在微流体装置中组装磁性胶体粒子 作者:WeijiaXie
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:0
- 作者:
L. Biswal;M. Pasquali;Laura Segatori;D. Li;G. Kini;Kaixuan Liu;Kung;Nan Du;D. Stark;Yu;Paul Choi;Madhu Thakur;Robert J. Wydra;Laura E Timmerman - 通讯作者:
Laura E Timmerman
Lipid bilayer phase transformations detected using microcantilevers.
使用微悬臂梁检测脂质双层相变。
- DOI:
10.1021/jp4095112 - 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
Jinghui Wang;Kai;Laura Segatori;S. Biswal - 通讯作者:
S. Biswal
Novel Approaches to Label the Surface of S. aureus with DBCO for Click Chemistry-Mediated Deposition of Sensitive Cargo
用于点击化学介导的敏感货物沉积的用 DBCO 标记金黄色葡萄球菌表面的新方法
- DOI:
10.1021/acs.bioconjchem.4c00575 - 发表时间:
2025-06-18 - 期刊:
- 影响因子:3.900
- 作者:
Tsvetelina H. Baryakova;Chia-Chien Hsu;Laura Segatori;Kevin J. McHugh - 通讯作者:
Kevin J. McHugh
Lacidipine remodels protein folding and Ca 2+ homeostasis in Gaucher's disease fibroblasts: a mechanism to rescue mutant glucocerebrosidase.
拉西地平重塑戈谢病成纤维细胞中的蛋白质折叠和 Ca 2 稳态:拯救突变型葡萄糖脑苷脂酶的机制。
- DOI:
10.1016/j.chembiol.2011.04.008 - 发表时间:
2011 - 期刊:
- 影响因子:0
- 作者:
Fan Wang;A. Chou;Laura Segatori - 通讯作者:
Laura Segatori
Laura Segatori的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laura Segatori', 18)}}的其他基金
Novel mammalian cell-based devices that sense and respond
基于哺乳动物细胞的新型感知和响应设备
- 批准号:
2036109 - 财政年份:2021
- 资助金额:
$ 38.69万 - 项目类别:
Continuing Grant
Engineering nanoparticles and nanostructures with precise and tunable modalities of interaction with the autophagy-lysosome system
工程纳米粒子和纳米结构与自噬-溶酶体系统具有精确且可调节的相互作用方式
- 批准号:
1805317 - 财政年份:2018
- 资助金额:
$ 38.69万 - 项目类别:
Standard Grant
A platform for targeted, post-translational control of protein levels in mammalian cells
用于哺乳动物细胞中蛋白质水平的靶向翻译后控制的平台
- 批准号:
1615562 - 财政年份:2016
- 资助金额:
$ 38.69万 - 项目类别:
Standard Grant
CAREER: Engineering cellular clearance pathways using nanoparticles
职业:使用纳米粒子设计细胞清除途径
- 批准号:
1254318 - 财政年份:2013
- 资助金额:
$ 38.69万 - 项目类别:
Continuing Grant
Understanding the impact of engineered nanoparticles on the lysosome-autophagy system
了解工程纳米粒子对溶酶体自噬系统的影响
- 批准号:
1336053 - 财政年份:2013
- 资助金额:
$ 38.69万 - 项目类别:
Standard Grant
Enhancing the innate cellular degradation capacity
增强先天细胞降解能力
- 批准号:
1159640 - 财政年份:2012
- 资助金额:
$ 38.69万 - 项目类别:
Standard Grant
EAGER: Engineering Molecular Sensors Of Endoplasmic Reticulum-Associated Degradation (ERAD)
EAGER:内质网相关降解(ERAD)的工程分子传感器
- 批准号:
1112783 - 财政年份:2011
- 资助金额:
$ 38.69万 - 项目类别:
Standard Grant
相似国自然基金
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
- 批准号:82371660
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Next Generation Majorana Nanowire Hybrids
- 批准号:
- 批准年份:2020
- 资助金额:20 万元
- 项目类别:
二次谐波非线性光学显微成像用于前列腺癌的诊断及药物疗效初探
- 批准号:30470495
- 批准年份:2004
- 资助金额:20.0 万元
- 项目类别:面上项目
相似海外基金
Mentoring the next generation of trainees in patient-oriented, community engaged research in obesity and health equity
指导下一代学员进行以患者为中心、社区参与的肥胖和健康公平研究
- 批准号:
10662072 - 财政年份:2023
- 资助金额:
$ 38.69万 - 项目类别:
Next generation transcranial ultrasound-based neuromodulation using phase shift nanoemulsions
使用相移纳米乳剂的下一代经颅超声神经调节
- 批准号:
10577371 - 财政年份:2023
- 资助金额:
$ 38.69万 - 项目类别:
Collaborative Research: Discriminating Between Galactic Feedback Models with Next Generation Observations
合作研究:区分银河反馈模型与下一代观测
- 批准号:
2346977 - 财政年份:2023
- 资助金额:
$ 38.69万 - 项目类别:
Standard Grant
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
- 批准号:
10585038 - 财政年份:2023
- 资助金额:
$ 38.69万 - 项目类别:
AIVIS: Next Generation Vigilant Information Seeking Artificial Intelligence-based Clinical Decision Support for Sepsis
AIVIS:下一代警惕信息寻求基于人工智能的脓毒症临床决策支持
- 批准号:
10699457 - 财政年份:2023
- 资助金额:
$ 38.69万 - 项目类别:
CIF:Small: Asynchrony and Limited Feedback in Next Generation Multiple Access
CIF:Small:下一代多路访问中的异步和有限反馈
- 批准号:
2328075 - 财政年份:2023
- 资助金额:
$ 38.69万 - 项目类别:
Standard Grant
"Extended dosing" immunization to enhance humoral immunity to next-generation vaccines
“延长剂量”免疫增强对下一代疫苗的体液免疫
- 批准号:
10638732 - 财政年份:2023
- 资助金额:
$ 38.69万 - 项目类别:
The CU Learning Disabilities (LD) Leadership Core: Scaffolding a Growing Center of Environmental LD Research and The Next generation of LD Scholars
CU 学习障碍 (LD) 领导核心:搭建不断发展的环境 LD 研究中心和下一代 LD 学者
- 批准号:
10533149 - 财政年份:2022
- 资助金额:
$ 38.69万 - 项目类别:
ID-Cap System: Next generation ingestible sensors for medication adherence measurement
ID-Cap 系统:用于药物依从性测量的下一代可摄入传感器
- 批准号:
10475453 - 财政年份:2022
- 资助金额:
$ 38.69万 - 项目类别:














{{item.name}}会员




